mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors That Progress on Rapalog Therapy and Delays Cardiac Impairment
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-0058
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2017
Authors
Publisher
American Association for Cancer Research (AACR)